Reference
Roncato R, et al. Cost evaluation of irinotecan-related toxicities associated with the UGT1A1*28 patient genotype. Clinical Pharmacology and Therapeutics : 11 Jan 2017. Available from: URL: http://doi.org/10.1002/cpt.615
Rights and permissions
About this article
Cite this article
UGT1A1*28 genotyping reduces irinotecan toxicity costs. Reactions Weekly 1635, 12 (2017). https://doi.org/10.1007/s40278-017-25261-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-25261-4